Khiron Life Sciences Corp. (OTCMKTS:KHRNF – Get Rating) saw a large growth in short interest in November. As of November 15th, there was short interest totalling 189,700 shares, a growth of 6.0% from the October 31st total of 178,900 shares. Based on an average daily volume of 140,300 shares, the short-interest ratio is presently 1.4 days.

Khiron Life Sciences Stock Performance

Shares of OTCMKTS:KHRNF opened at $0.06 on Monday. The company's fifty day moving average is $0.07 and its 200-day moving average is $0.09. Khiron Life Sciences has a 52 week low of $0.05 and a 52 week high of $0.22.

Wall Street Analysts Forecast Growth

Separately, Mackie downgraded shares of Khiron Life Sciences from a "buy" rating to a "hold" rating in a research note on Wednesday, November 30th.

About Khiron Life Sciences

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.

Further Reading

• Get a free copy of the StockNews.com research report on Khiron Life Sciences (KHRNF)
• Is Salesforce Stock a Bargain Down Here?
• Intel is a Sleeping Giant Ready to Awaken
• Why CSL Ltd Stock Could Be Worth a Look
• MarketBeat: Week in Review 11/28 – 12/02
• Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?

Receive News & Ratings for Khiron Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Khiron Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.